Fw: e-Newsletter for Tuesday, March 13, 2012

[Guest guest]

From: "HIVandHepatitis.com" <newsletter@...>Date: Tue, 13 Mar 2012 17:08:35 -0400 (EDT)<nelsonvergel@...>Reply newsletter@...Subject: e-Newsletter for Tuesday, March 13, 2012Having trouble viewing this email?Click here e-Newsletter for Tuesday, March 13, 2012 Hepatitis C and HIV/HCV Coinfection HIV/HCV Coinfection News from CROI 2012 Hepatitis C was a major topic at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) last week in Seattle. Liz Highleyman from HIVandHepatitis.com spoke with Dieterich and Sherman about advances in the field, with a focus on HIV/HCV coinfected patients. Phase 3 Trials Now Testing HCV Drug TMC435 in Genotype 1 Non-responders and Genotype 4 Patients The next-generation hepatitis C virus (HCV) protease inhibitor TMC435 is now entering 2 new Phase 3 clinical trials, to be used in combination with pegylated interferon/ribavirin for hard-to-treat HCV genotype 1 patients as well as those with genotype 4, according to a company press release. HIV/AIDS 4-in-1 Elvitegravir Quad Pill Matches Efavirenz and Atazanavir Combos The Quad single-tablet regimen, an all-in-one pill containing the experimental integrase inhibitor elvitegravir plus 2 other antiretroviral drugs and a novel boosting agent, was as effective as the widely used Atripla combination but with fewer neuropsychiatric side-effects, researchers reported at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this week in Seattle. In a companion study the Quad also matched boosted atazanavir (Reyataz). HIV Superinfections May Happen as Often as First Infections Two studies of people with HIV in Rakai, Uganda, and Mombasa, Kenya, presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) last week in Seattle show that the rate at which they acquired second, subsequent strains of HIV was about the same as the HIV incidence rate in the general population. Forward emailThis email was sent to nelsonvergel@... by newsletter@... | Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy.HIVandHepatitis.com | 584 Castro Street #272 | San Francisco | CA | 94114